Xerostomia (Dry Mouth): Causes, Effects on Your Teeth, and Management

Xerostomia is the subjective sensation of dry mouth, meaning it is what the patient experiences. It is distinct from hyposalivation, which is the objectively measured reduction in salivary flow rate. The two often occur together, but not always. A patient can have reduced measurable saliva flow without feeling dry, and some patients report significant dryness with near-normal salivary output, often because of changes in saliva composition rather than quantity.

Saliva serves functions that go far beyond simply making swallowing comfortable. It contains antimicrobial proteins including lysozyme, lactoferrin, and secretory IgA that suppress oral pathogens. It buffers acid produced by bacteria and neutralizes dietary acids. It provides a constant supply of calcium and phosphate that remineralizes enamel. It mechanically rinses food debris and bacteria from tooth surfaces and gum tissue. And it contains mucins that lubricate the mucosal surfaces, protecting them from friction and desiccation.

When salivary flow is significantly reduced, all of these protective functions are impaired simultaneously. The result is an accelerated deterioration of oral health that affects multiple tissues at once, not just one problem in isolation.

Medications are the most common cause of xerostomia in adults, affecting an estimated 30 to 40% of people who take three or more daily medications. The drug classes most consistently implicated include anticholinergics, antidepressants (both tricyclics and many SSRIs and SNRIs), antihistamines (both first and second generation), antihypertensives, diuretics, and antipsychotics. A more detailed breakdown of specific drug classes and their mechanisms is covered in a companion post.

The mechanism is usually inhibition of the salivary glands' parasympathetic nerve input, which drives most salivary secretion. Drugs with anticholinergic properties block muscarinic receptors, reducing gland responsiveness to stimulation. Some medications directly impair gland function through other mechanisms. Diuretics reduce overall body fluid volume, which lowers the substrate available for saliva production.

Medication-induced xerostomia is particularly relevant in older adults, who are more likely to take multiple medications and whose salivary gland reserve capacity is already reduced with age. Polypharmacy, taking five or more medications simultaneously, dramatically increases the likelihood and severity of drug-induced dry mouth.

Sjogren's syndrome is an autoimmune condition in which the immune system attacks the salivary and lacrimal (tear) glands, among other exocrine glands. Primary Sjogren's involves the glands themselves; secondary Sjogren's occurs alongside other autoimmune conditions such as rheumatoid arthritis or lupus. It produces severe and persistent dry mouth and dry eyes, with salivary function sometimes reduced by 90% or more in advanced cases. Dental management of Sjogren's patients requires intensive preventive protocols.

Head and neck radiation therapy for cancer, particularly when the salivary glands fall within the radiation field, causes progressive gland destruction proportional to the radiation dose received. Doses above 26 Gy to major salivary glands produce measurable hyposalivation; doses above 40 Gy can cause permanent severe salivary dysfunction. Modern intensity-modulated radiation therapy (IMRT) is designed in part to spare salivary glands when possible, but many patients still experience significant long-term dry mouth.

Other systemic contributors include uncontrolled diabetes (which affects salivary composition and flow), HIV infection, anxiety and depression (through autonomic nervous system effects), dehydration from any cause, and chronic mouth breathing due to nasal obstruction or sleep apnea. Many of these are at least partially reversible with appropriate medical management.

The most dramatic dental effect of significant xerostomia is rampant decay. Cavities that in a normal salivary environment would develop slowly and primarily in predictable high-risk sites (pits, fissures, between teeth) occur rapidly in multiple sites simultaneously, including on root surfaces, at the gumline, and even on cusp tips and smooth enamel surfaces that rarely decay in normally hydrated mouths. This pattern of decay, cervical caries affecting multiple teeth in a patient with previously good hygiene, should trigger evaluation for salivary dysfunction.

Acid erosion accelerates without saliva buffering. Dietary acids, gastric reflux, and even the natural carbohydrate fermentation of normal meals produce sustained drops in oral pH that saliva normally neutralizes within minutes. Without adequate saliva, pH remains low for longer periods, demineralizing enamel continuously.

Gum tissue in a dry-mouth environment becomes more susceptible to infection. Saliva's antimicrobial proteins hold bacterial populations in check on mucosal surfaces as well as tooth surfaces. Their reduction allows opportunistic organisms including Candida albicans to flourish, which is why oral candidiasis is common in patients with severe xerostomia. The tissue itself becomes friable, prone to ulceration from minor trauma, and slow to heal.

For medication-induced xerostomia, the most effective intervention is medication review. Many drug classes have alternatives with lower anticholinergic burden. Your prescribing physician may be able to substitute a drug with fewer salivary effects, reduce the dose, or adjust the timing (taking anticholinergic medications earlier in the day so the peak effect does not coincide with sleep). Medication changes should be discussed with your prescribing physician, not made unilaterally.

Salivary substitutes and stimulants address symptoms without changing the underlying cause. Artificial saliva products (sprays, gels, and lozenges) provide temporary lubrication. Salivary stimulants including sugarless gum and sugar-free hard candies mechanically stimulate residual gland function, provided some gland capacity remains. Prescription medications including pilocarpine (Salagen) and cevimeline (Evoxac) are parasympathomimetic drugs that directly stimulate muscarinic receptors, increasing saliva output in patients with functioning but underperforming glands. They are particularly useful in Sjogren's syndrome and post-radiation patients.

Fluoride use is more critical, not optional, in patients with significant xerostomia. High-concentration fluoride toothpaste, fluoride varnish at every professional visit, and sometimes prescription fluoride gel in a custom tray are standard preventive measures. Remineralizing products with calcium phosphate (such as MI Paste) may provide additional benefit. The goal is to compensate chemically for the loss of saliva's natural remineralization capacity.

Consistent hydration throughout the day is a simple and underappreciated tool. Sipping water frequently, particularly during and after meals, partially compensates for reduced salivary rinsing. Avoid caffeine, alcohol, and acidic beverages as much as possible, since all three worsen dryness or acid exposure. Breathing through the nose rather than the mouth preserves mucosal moisture.

Diet modification helps reduce decay risk when saliva is insufficient. Reducing frequency of fermentable carbohydrate consumption, particularly sticky or sugary foods that cling to tooth surfaces, limits the acid challenges that unprotected teeth must endure. Eating meals rather than grazing continuously reduces the total time pH is low.

Sleeping with a humidifier adds ambient moisture that reduces the drying effect of overnight mouth breathing, which is common in patients with dry mouth. Some patients find that petroleum-free lip balm and oral gels applied at bedtime reduce the discomfort of waking with severely dry, cracked lips and mucosa.